Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin

BACKGROUND: Ifosfamide has recently used as the intravenous component of bidirectional intraoperative chemotherapy (BDIC) with hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin. Little is known about the systemic toxicities of this BDIC regimen. Therefore, this study...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pleura Peritoneum
Glavni autori: Hakeam, Hakeam, Ayman, Azzam, Waleed, Al Taweel, Amen, Tarek
Format: Artigo
Jezik:Inglês
Izdano: De Gruyter 2019
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6881663/
https://ncbi.nlm.nih.gov/pubmed/31799375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/pp-2019-0025
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items